Percheron Therapeutics Limited (ASX:PER)

Percheron Therapeutics Statistics

Total Valuation

ASX:PER has a market cap or net worth of AUD 8.70 million. The enterprise value is -1.44 million.

Market Cap	8.70M
Enterprise Value	-1.44M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:PER has 1.09 billion shares outstanding. The number of shares has increased by 16.22% in one year.

Current Share Class	1.09B
Shares Outstanding	1.09B
Shares Change (YoY)	+16.22%
Shares Change (QoQ)	+19.78%
Owned by Insiders (%)	20.36%
Owned by Institutions (%)	9.77%
Float	780.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.83
PB Ratio	0.87
P/TBV Ratio	0.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.10
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.09

Financial Position

The company has a current ratio of 5.10, with a Debt / Equity ratio of 0.00.

Current Ratio	5.10
Quick Ratio	4.83
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-998.32

Financial Efficiency

Return on equity (ROE) is -154.10% and return on invested capital (ROIC) is -95.89%.

Return on Equity (ROE)	-154.10%
Return on Assets (ROA)	-69.10%
Return on Invested Capital (ROIC)	-95.89%
Return on Capital Employed (ROCE)	-149.01%
Weighted Average Cost of Capital (WACC)	11.21%
Revenue Per Employee	225,132
Profits Per Employee	-1.87M
Employee Count	8
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.25
52-Week Price Change	n/a
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	54.73
Average Volume (20 Days)	680,878

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:PER had revenue of AUD 1.80 million and -14.92 million in losses. Loss per share was -0.01.

Revenue	1.80M
Gross Profit	1.63M
Operating Income	-14.91M
Pretax Income	-14.92M
Net Income	-14.92M
EBITDA	-14.84M
EBIT	-14.91M
Loss Per Share	-0.01

Balance Sheet

The company has 10.17 million in cash and 25,865 in debt, with a net cash position of 10.14 million or 0.01 per share.

Cash & Cash Equivalents	10.17M
Total Debt	25,865
Net Cash	10.14M
Net Cash Per Share	0.01
Equity (Book Value)	10.00M
Book Value Per Share	0.01
Working Capital	9.97M

Cash Flow

In the last 12 months, operating cash flow was -15.64 million and capital expenditures -7,240, giving a free cash flow of -15.65 million.

Operating Cash Flow	-15.64M
Capital Expenditures	-7,240
Free Cash Flow	-15.65M
FCF Per Share	-0.01

Margins

Gross Margin	90.71%
Operating Margin	-827.68%
Pretax Margin	-828.51%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:PER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.22%
Shareholder Yield	-16.22%
Earnings Yield	-171.53%
FCF Yield	-179.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 6, 2013. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 6, 2013
Split Type	Reverse
Split Ratio	0.1

Scores

ASX:PER has an Altman Z-Score of -3.74 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.74
Piotroski F-Score	1